Nanhua Bio Medicine Stock Market Capitalization
| 000504 Stock | 10.37 0.07 0.68% |
Nanhua Bio Medicine fundamentals help investors to digest information that contributes to Nanhua Bio's financial success or failures. It also enables traders to predict the movement of Nanhua Stock. The fundamental analysis module provides a way to measure Nanhua Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nanhua Bio stock.
Nanhua | Market Capitalization |
Nanhua Bio Medicine Company Market Capitalization Analysis
Nanhua Bio's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Nanhua Bio Market Capitalization | 3.61 B |
Most of Nanhua Bio's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nanhua Bio Medicine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
Based on the recorded statements, the market capitalization of Nanhua Bio Medicine is about 3.61 B. This is 79.36% lower than that of the Media sector and significantly higher than that of the Communication Services industry. The market capitalization for all China stocks is 81.04% higher than that of the company.
Nanhua Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nanhua Bio's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nanhua Bio could also be used in its relative valuation, which is a method of valuing Nanhua Bio by comparing valuation metrics of similar companies.Nanhua Bio is currently under evaluation in market capitalization category among its peers.
Nanhua Fundamentals
| Return On Equity | -0.31 | ||||
| Return On Asset | -0.0455 | ||||
| Profit Margin | (0.30) % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 3.13 B | ||||
| Shares Outstanding | 330.02 M | ||||
| Shares Owned By Insiders | 13.01 % | ||||
| Shares Owned By Institutions | 40.52 % | ||||
| Price To Book | 13.76 X | ||||
| Price To Sales | 28.99 X | ||||
| Revenue | 136.79 M | ||||
| Gross Profit | 127.36 M | ||||
| EBITDA | (38.19 M) | ||||
| Net Income | (28.17 M) | ||||
| Total Debt | 28.12 M | ||||
| Book Value Per Share | 0.75 X | ||||
| Cash Flow From Operations | 36.28 M | ||||
| Earnings Per Share | (0.12) X | ||||
| Beta | 0.69 | ||||
| Market Capitalization | 3.61 B | ||||
| Total Asset | 771.38 M | ||||
| Retained Earnings | (531.1 M) | ||||
| Working Capital | 202.45 M | ||||
| Net Asset | 771.38 M |
About Nanhua Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nanhua Bio Medicine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nanhua Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nanhua Bio Medicine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Nanhua Stock
Nanhua Bio financial ratios help investors to determine whether Nanhua Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanhua with respect to the benefits of owning Nanhua Bio security.